Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.
Neuberger M, Weiß C, Goly N, Skladny J, Nitschke K, Wessels F, Kowalewski KF, Waldbillig F, Hartung F, Nientiedt M, Egen L, Herrmann J, Jarczyk J, Walach MT, Kriegmair MC, Westhoff N, Worst TS, Nuhn P.
Neuberger M, et al. Among authors: walach mt.
Discov Oncol. 2022 Dec 15;13(1):140. doi: 10.1007/s12672-022-00603-0.
Discov Oncol. 2022.
PMID: 36522513
Free PMC article.